3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Polycystic Ovary Syndrome
3
Peripheral Nervous System Diseases
3
Ovarian Neoplasms
3
Carcinoma, Hepatocellular
3
Stomatitis
2
Stomach Neoplasms
2
Ototoxicity
2
Neurofibromatosis 1
2
Liver Neoplasms
2
Hearing Loss
2
Head and Neck Neoplasms
2
Weight Loss
1
Ulcer
1
Tongue Neoplasms
1
Tomaculous neuropathy
1
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Radiation-Induced Mucositis
1
Radiation Pneumonitis
1
Pseudomyxoma Peritonei
1
Primary Myelofibrosis
1
Primary Graft Dysfunction
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Osteosarcoma
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Neuroma
1
Interventions
Pemetrexed
22
Cisplatin
20
Nivolumab
8
Gemcitabine
7
Carboplatin
7
durvalumab
5
Ipilimumab
5
Bevacizumab
5
pembrolizumab
4
Radiotherapy, Intensity-Modulated
4
tremelimumab
3
niraparib
3
Oxaliplatin
3
Drug Therapy
3
Cyclophosphamide
3
Cerebral Decortication
3
Blood Specimen Collection
3
sargramostim
2
Thoracoscopy
2
Surveys and Questionnaires
2
Sorafenib
2
Radiosurgery
2
Magnesium Sulfate
2
Leucovorin
2
Imatinib Mesylate
2
Hyperthermic Intraperitoneal Chemotherapy
2
Doxorubicin
2
Dexamethasone
2
tislelizumab
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Mesothelioma
×
Acetylcysteine
×
Clear all
NCT00637624
2022-08-25
NAC-PNP
Rijnstate Hospital
Phase NA
Terminated
69 enrolled